Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections
JAMA Surgery · 2025
DOI: 10.1001/jamasurg.2025.3789 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, 2025. Verfasst von Prateek Agarwal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Surgical Wound Infection, Drug Hypersensitivity, beta-Lactams, Anti-Bacterial Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Surgical site infections (SSIs) pose significant health and economic burdens. β-lactams are the recommended prophylactic antibiotics for most surgical procedures; however, the association of non–β-lactam antibiotics with SSI incidence is controversial.
Objective
To evaluate the association between reported β-lactam allergy status, β-lactam antibiotics, and SSIs across various surgical specialties. Design, Setting, and Participants This was a retrospective cohort study of a prospectively recorded database. The setting was a quaternary health center. Included in the study were patients who underwent surgery from January 2021 to February 2024. Exposures Study exposures included antibiotic choice and reported β-lactam allergy, with covariates including demographics, comorbidities, and procedure details. Main Outcomes and Measures The primary study outcome was 30- to 90-day SSI incidence.
Results
The study included 49 279 procedures across 10 specialties, with a total of 41 100 patients (mean [SD] age, 61.0 [15.9] years; range, 13-103 years; 21 237 male [51.7%]). Procedures with non–β-lactam antibiotic use had a higher incidence of SSI than procedures with β-lactam antibiotic use (2.2% vs 1.3%; risk ratio [RR], 1.69; 95% CI, 1.28-2.01; P < .001). Procedures in patients with reported β-lactam allergy had a higher incidence of SSI (1.8% vs 1.3%; RR, 1.38; 95% CI, 1.15-1.64; P = .003). These associations were present in logistic regression as well. However, on controlling for covariates and β-lactam allergy, non–β-lactam antibiotic use remained significantly associated with higher SSI incidence (odds ratio [OR], 1.33; 95% CI, 1.00-1.74; P = .04), whereas the association between β-lactam allergy and SSI incidence became nonsignificant (OR, 1.21; 95% CI, 0.97-1.49; P = .09). In subspecialty analysis, only orthopedic surgery retained a significant association between non–β-lactam use and increased SSI (OR, 3.01; 95% CI, 1.41-6.01; P = .003). Conclusions and Relevance This cohort study found that β-lactam prophylaxis was associated with significantly lower SSI rates than non–β-lactam agents, and a reported β-lactam allergy did not independently predict infection risk. Implementation of an allergy-focused stewardship guideline was associated with a marked reduction in non–β-lactam use, underscoring the importance of precise allergy assessment to avoid unnecessary alternative prophylaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Department of Infection Control and Hospital Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh Medical Center.
- Department of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Zitieren
APA
Agarwal, P., Kumar, R. P., Oleksiuk, L. M., Crall, V., Petrov, A. A., McCreary, E. K., Holder-Murray, J., Chang, Y. F., Agarwal, N., Hamilton, D. K., & Friedlander, R. M. (2025). Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections. JAMA Surgery. https://doi.org/10.1001/jamasurg.2025.3789
Vancouver
Agarwal P, Kumar RP, Oleksiuk LM, Crall V, Petrov AA, McCreary EK, et al. Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections. JAMA Surgery. 2025. doi:10.1001/jamasurg.2025.3789
BibTeX
@article{Agarwal2025,
author = {Agarwal, Prateek and Kumar, Rohit Prem and Oleksiuk, Louise-Marie and Crall, Victoria and Petrov, Andrej A and McCreary, Erin K and Holder-Murray, Jennifer and Chang, Yue-Fang and Agarwal, Nitin and Hamilton, D Kojo and Friedlander, Robert M},
title = {Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections},
journal = {JAMA Surgery},
year = {2025},
doi = {10.1001/jamasurg.2025.3789}
}
EUVIMED